OraSure Technologies, Inc. (OSUR)
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
$3.48-2.79%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
QuarterlyIQ Insights · OSUR
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 112.4 | 115.0 | 185.8 | 405.5 | 387.5 | 233.7 | 171.7 | 154.6 | 181.7 | 167.1 | 128.2 | 119.7 | 106.5 | 98.9 | 87.8 | 81.9 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 167.1 | 128.2 | 119.7 | 106.5 | 98.9 | 87.8 | 81.9 |
| Cost of Revenues | 64.6 | 66.8 | 106.4 | 233.8 | 239.0 | 116.1 | 69.9 | 60.0 | 68.1 | — | — | — | — | — | — | — |
| Gross Profit | 47.9 | 48.2 | 79.4 | 171.7 | 148.4 | 117.6 | 101.9 | 94.6 | 113.6 | 99.0 | 88.0 | 80.3 | 66.6 | 58.6 | 55.6 | 51.7 |
| Operating Expenses & Income | ||||||||||||||||
| R&D Expenses | 44.6 | 42.5 | 26.0 | 33.7 | 36.2 | 34.2 | 31.0 | 19.6 | 16.3 | 13.4 | 9.8 | 11.7 | 12.1 | 10.9 | 12.4 | 18.4 |
| Operating Income | (54.0) | (72.0) | (28.3) | 32.7 | (22.2) | (10.2) | (5.2) | 18.6 | 28.4 | 40.2 | 20.3 | 8.1 | (4.8) | (12.2) | (16.3) | (9.4) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | — | — | — | — | — | — | — | — | — | — | — | 0.2 | 0.2 | 0.2 | 0.3 |
| Interest & Investment Income | 6.3 | 8.1 | 11.5 | 5.9 | 1.6 | — | — | — | — | — | — | — | — | — | — | 0.1 |
| Net Interest Expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.3 |
| Asset Writedown | — | — | 4.4 | 10.8 | 17.1 | 0.0 | — | — | — | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | (46.6) | (64.6) | (16.0) | 56.3 | (15.7) | (9.3) | (3.5) | 21.3 | 31.7 | 41.0 | 20.3 | 8.8 | (4.3) | (12.0) | (16.5) | (9.7) |
| Income Tax Expense | (0.1) | 1.8 | 1.8 | 2.6 | 1.5 | 13.7 | 11.4 | 4.7 | 11.3 | 10.1 | 0.6 | 0.7 | 0.3 | (0.8) | (1.4) | (0.9) |
| Net Income | ||||||||||||||||
| Net Income | (49.1) | (68.7) | (19.5) | 53.7 | (17.1) | (23.0) | (14.9) | 16.7 | 20.4 | 30.9 | 19.7 | 8.2 | (4.6) | (11.2) | (15.1) | (8.8) |
| Per Share | ||||||||||||||||
| Basic EPS | (0.71) | (0.94) | (0.26) | 0.73 | (0.24) | (0.32) | 0.22 | 0.27 | 0.33 | 0.52 | 0.35 | 0.14 | (0.08) | (0.20) | (0.29) | — |
| Diluted EPS | (0.70) | (0.94) | (0.26) | 0.72 | (0.24) | (0.32) | 0.22 | 0.27 | 0.33 | 0.51 | 0.35 | 0.14 | (0.08) | (0.20) | (0.29) | — |
| Revenue per Share | 1.60 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 69.0 | 73.5 | 74.4 | 73.3 | 72.5 | 72.0 | 67.5 | 61.7 | 61.1 | 59.1 | 55.6 | 56.4 | 55.9 | 55.6 | 51.5 | — |
| Diluted Weighted Avg Shares | 70.2 | 73.5 | 74.4 | 74.4 | 72.5 | 72.0 | 67.5 | 62.2 | 62.5 | 61.0 | 56.5 | 56.8 | 55.9 | 55.6 | 51.5 | — |
| Supplemental | ||||||||||||||||
| EBITDA | — | (61.8) | (17.4) | 53.6 | (6.8) | 1.5 | 4.2 | 26.0 | 34.9 | 46.3 | 26.0 | 13.9 | 1.5 | (5.6) | (9.0) | (4.5) |
| EBIT | (54.0) | (72.0) | (28.3) | 32.7 | (22.2) | (10.2) | (5.2) | 18.6 | 28.4 | 40.2 | 20.3 | 8.1 | (4.8) | (12.2) | (16.3) | (9.4) |
| Effective Tax Rate | 0.3% | — | — | 4.6% | -9.3% | -147.5% | -323.4% | 21.9% | 35.7% | 24.6% | 3.0% | 7.5% | -8.0% | 6.5% | 8.5% | 8.9% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.